EHMT2 and cancer: This assay confirmed that both the treatment of cancer cells with EHMT2 inhibitors (UNC0642 and A366) and the knockdown of EHMT2 in cancer cells significantly increased NK cell-mediated cytotoxicity in UM cell lines (Appendix Fig. S2D,E).